Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Martin

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Lung Cancer|November 1, 2023
TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical ResectionRoss Andrew Soo, Filippo de Marinis, Ji-Youn Han, et al.
Biomedical Materials (Bristol, England)|May 23, 2023
Bioprinted cancer-stromal<i>in-vitro</i>models in a decellularized ECM-based bioink exhibit progressive remodeling and maturationJacqueline Kort-Mascort, Molly L Shen, Emma Martin, et al.
The Lancet. Digital Health|February 14, 2026
Emerging radar-based technologies for cuffless blood pressure monitoring-a systematic reviewDebbie Falconer, Bernard Brincat, Michele Orini, et al.
Nanoscale|July 21, 2010
Intracellular imaging of HeLa cells by non-functionalized NaYF4 : Er3+, Yb3+ upconverting nanoparticlesFiorenzo Vetrone, Rafik Naccache, Angeles Juarranz de la Fuente, et al.
The Journal of Allergy and Clinical Immunology|May 2, 2013
TNF-α-mediated bronchial barrier disruption and regulation by src-family kinase activationMichelle A Hardyman, Emily Wilkinson, Emma Martin, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 30, 2026
Microstructural disease and hypoperfusion in dilated cardiomyopathy underpin midwall septal fibrosisFiona Ts Chan, Sam Coveney, Sean L Zheng, et al.
Circulation. Cardiovascular Imaging|December 17, 2025
Higher Life-Course Blood Pressure Associates With Reduced Myocardial Perfusion in Older Age: Insights From MyoFit46Constantin-Cristian Topriceanu, Matthew Webber, Hunain Shiwani, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 1, 2024
Corrigendum to "Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) trial: Study protocol and statistical analysis plan" [Crit Care Resuscit 25 (2023) 118-125]Aidan Burrell, Sze Ng, Kelly Ottosen, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) Trial: Study Protocol and Statistical Analysis PlanAidan Burrell, Sze Ng, Kelly Ottosen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Lung Cancer|November 1, 2023
TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical ResectionRoss Andrew Soo, Filippo de Marinis, Ji-Youn Han, et al.
Biomedical Materials (Bristol, England)|May 23, 2023
Bioprinted cancer-stromal<i>in-vitro</i>models in a decellularized ECM-based bioink exhibit progressive remodeling and maturationJacqueline Kort-Mascort, Molly L Shen, Emma Martin, et al.
The Lancet. Digital Health|February 14, 2026
Emerging radar-based technologies for cuffless blood pressure monitoring-a systematic reviewDebbie Falconer, Bernard Brincat, Michele Orini, et al.
Nanoscale|July 21, 2010
Intracellular imaging of HeLa cells by non-functionalized NaYF4 : Er3+, Yb3+ upconverting nanoparticlesFiorenzo Vetrone, Rafik Naccache, Angeles Juarranz de la Fuente, et al.
The Journal of Allergy and Clinical Immunology|May 2, 2013
TNF-α-mediated bronchial barrier disruption and regulation by src-family kinase activationMichelle A Hardyman, Emily Wilkinson, Emma Martin, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 30, 2026
Microstructural disease and hypoperfusion in dilated cardiomyopathy underpin midwall septal fibrosisFiona Ts Chan, Sam Coveney, Sean L Zheng, et al.
Circulation. Cardiovascular Imaging|December 17, 2025
Higher Life-Course Blood Pressure Associates With Reduced Myocardial Perfusion in Older Age: Insights From MyoFit46Constantin-Cristian Topriceanu, Matthew Webber, Hunain Shiwani, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 1, 2024
Corrigendum to "Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) trial: Study protocol and statistical analysis plan" [Crit Care Resuscit 25 (2023) 118-125]Aidan Burrell, Sze Ng, Kelly Ottosen, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) Trial: Study Protocol and Statistical Analysis PlanAidan Burrell, Sze Ng, Kelly Ottosen, et al.
Pageof 4